Eli Lilly To Buy CrossBridge And Its Dual-Payload ADC Tech

 
• By Alaric DeArment
  
Eli Lilly said it would spend up to $300m to acquire CrossBridge Bio and its dual-payload ADC technology. (Alaric DeArment)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business